MarketPeel
Insider Trading Intelligence
KR

Kanya Rajangam

NKTX
CHIEF MEDICAL OFFICER · NKARTA, INC. · CIK 0001816676
FILING MIX · LIFETIME67%/33%
BUYS
14
SELLS
7
TOTAL VALUE
$605.7K
COMPANIES
2
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
151,643
AVG SELL PX
$39.36
TRADE KIND
SHOWING 21 / 21
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Kanya Rajangam, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-1.57%+0.64%-2.20%-1.93%
14d3+66.67%-3.97%+0.62%-4.58%-8.52%
30d3+100.00%-17.92%-2.43%-15.49%-13.69%
60d3+100.00%-29.57%-11.67%-17.90%-14.85%
90d3+100.00%-30.15%-2.57%-27.58%-16.15%
180d3+100.00%-62.81%+4.10%-66.91%-64.16%
1y3+100.00%-72.13%+7.85%-79.98%-91.05%
2y3(2 pending)+100.00%-94.32%+4.26%-98.58%-98.58%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NKTX · 76,800 shares · as of Jan 14, 2022
019,20038,40057,60076,80020212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 14 buys / 7 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SNTI
SENTI BIOSCIENCES, INC.
SALE
Pres. & Chief Med. & Dev. Off.
10,75774,843Mar 9, 2026Mar 9, 2026View →
SNTI
SENTI BIOSCIENCES, INC.
SALE
Pres. & Chief Med. & Dev. Off.
1,38485,600Feb 2, 2026Feb 3, 2026View →
SNTI
SENTI BIOSCIENCES, INC.
SALE
Pres. & Chief Med. & Dev. Off.
33$2,250.00$74.3K0Mar 10, 2025Mar 11, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASE
Pres. & Chief Med. & Dev. Off.
33,000$2.25$74.3K33,000Mar 10, 2025Mar 11, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
78,36386,984Mar 7, 2025Mar 10, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
235,088235,088Mar 6, 2025Mar 10, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
SALE
Pres. & Chief Med. & Dev. Off.
182$4.37$7958,621Feb 6, 2025Feb 6, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
SALE
Pres. & Chief Med. & Dev. Off.
1,297$4.07$5.3K8,803Feb 4, 2025Feb 6, 2025View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
33$2,250.00$74.3K33Dec 9, 2024Dec 10, 2024View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
49,50049,500Dec 9, 2024Dec 10, 2024View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
101,000101,000Feb 1, 2024Feb 2, 2024View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
152,000152,000Feb 1, 2024Feb 2, 2024View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
130,000130,000Feb 1, 2023Feb 2, 2023View →
SNTI
SENTI BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
327,750327,750Jul 18, 2022Jul 20, 2022View →
NKTX
NKARTA, INC.
PURCHASEGRANT
Stock grant
12,80012,800Jan 14, 2022Jan 19, 2022View →
NKTX
NKARTA, INC.
PURCHASEGRANT
Stock grant
76,80076,800Jan 14, 2022Jan 19, 2022View →
NKTX
NKARTA, INC.
SALE
Chief Medical Officer
10,00044,054Aug 5, 2021Aug 9, 2021View →
NKTX
NKARTA, INC.
PURCHASE
Chief Medical Officer
10,000$0.41$4.1K10,000Aug 5, 2021Aug 9, 2021View →
NKTX
NKARTA, INC.
SALE
Chief Medical Officer
10,000$37.28$372.8K0Aug 5, 2021Aug 9, 2021View →
NKTX
NKARTA, INC.
PURCHASEGRANT
Stock grant
52,50052,500Jan 8, 2021Jan 12, 2021View →
NKTX
NKARTA, INC.
PURCHASEGRANT
Stock grant
70,60070,600Jul 9, 2020Jul 10, 2020View →
Other insiders · NKTX
Loading peer insiders…
About this filer
CIK 0001816676
ROLE
Chief Medical Officer
PRIMARY
NKTX
COMPANIES
2
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001816676DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback